Skip to main content

Abstract

Skin picking consumes hours a day for some individuals, causing disfigurement and interfering with social or work life. Skin picking disorder has a prevalence of 1%–5% and can arise at any age, often after the onset of a dermatological condition. Although it has similarities to obsessive-compulsive disorder and body dysmorphic disorder, it is distinguished by a personal or family history of grooming disorders and a lack of preoccupation with appearance. A dermatologist should determine whether the patient has an underlying skin condition and whether medical treatment is needed.

Abstract

Although skin picking has been documented in the medical literature since the 19th century, only now is it receiving serious consideration as a DSM psychiatric disorder in discussions for DSM-5. Recent community prevalence studies suggest that skin picking disorder appears to be as common as many other psychiatric disorders, with reported prevalences ranging from 1.4% to 5.4%. Clinical evaluation of patients with skin picking disorder entails a broad physical and psychiatric examination, encouraging an interdisciplinary approach to evaluation and treatment. Approaches to treatment should include cognitive-behavioral therapy (including habit reversal or acceptance-enhanced behavior therapy) and medication (serotonin reuptake inhibitors, N-acetylcysteine, or naltrexone). Based on clinical experience and research findings, the authors recommend several management approaches to skin picking disorder.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1143 - 1149
PubMed: 23128921

History

Received: 17 April 2012
Accepted: 21 May 2012
Published online: 1 November 2012
Published in print: November 2012

Authors

Affiliations

Jon E. Grant, M.D., M.P.H.
From the Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago; the Department of Psychiatry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K.; the Trichotillomania Clinic and Research Unit, Massachusetts General Hospital and Harvard Medical School, Boston; the MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa; and the Department of Psychiatry and Mental Health, University of Cape Town, South Africa.
Brian L. Odlaug, M.P.H.
From the Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago; the Department of Psychiatry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K.; the Trichotillomania Clinic and Research Unit, Massachusetts General Hospital and Harvard Medical School, Boston; the MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa; and the Department of Psychiatry and Mental Health, University of Cape Town, South Africa.
Samuel R. Chamberlain, M.D., Ph.D.
From the Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago; the Department of Psychiatry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K.; the Trichotillomania Clinic and Research Unit, Massachusetts General Hospital and Harvard Medical School, Boston; the MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa; and the Department of Psychiatry and Mental Health, University of Cape Town, South Africa.
Nancy J. Keuthen, Ph.D.
From the Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago; the Department of Psychiatry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K.; the Trichotillomania Clinic and Research Unit, Massachusetts General Hospital and Harvard Medical School, Boston; the MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa; and the Department of Psychiatry and Mental Health, University of Cape Town, South Africa.
Christine Lochner, Ph.D.
From the Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago; the Department of Psychiatry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K.; the Trichotillomania Clinic and Research Unit, Massachusetts General Hospital and Harvard Medical School, Boston; the MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa; and the Department of Psychiatry and Mental Health, University of Cape Town, South Africa.
Dan J. Stein, M.D., Ph.D.
From the Department of Psychiatry and Behavioral Neurosciences, University of Chicago, Chicago; the Department of Psychiatry, University of Cambridge, Addenbrooke’s Hospital, Cambridge, U.K.; the Trichotillomania Clinic and Research Unit, Massachusetts General Hospital and Harvard Medical School, Boston; the MRC Unit on Anxiety and Stress Disorders, Department of Psychiatry, University of Stellenbosch, South Africa; and the Department of Psychiatry and Mental Health, University of Cape Town, South Africa.

Notes

Address correspondence to Dr. Grant ([email protected]).

Competing Interests

Dr. Grant has received research grants from the National Center for Responsible Gaming, Forest Pharmaceuticals, Psyadon Pharmaceuticals, Transcept Pharmaceuticals, and the University of South Florida, serves as the editor-in-chief of the Journal of Gambling Studies, and has received royalties from Oxford University Press, Norton, and McGraw-Hill. Mr. Odlaug has received research funding from the Trichotillomania Learning Center and honoraria from Oxford University Press and Current Medicine Group, LLC. Dr. Chamberlain has consulted for Cambridge Cognition, P1Vital, Shire, and Eli Lilly. Dr Keuthen has received research funding from the Trichotillomania Learning Center, has equity in Pfizer, Merck, GlaxoSmithKline, and Johnson & Johnson, and receives royalties from New Harbinger Publications. Drs. Stein and Lochner report no financial relationships with commercial interests.

Funding Information

Supported by a Center for Excellence in Gambling Research grant by the National Center for Responsible Gaming and an American Recovery and Reinvestment Act (ARRA) grant from the National Institute on Drug Abuse (1RC1DA028279-01) to Dr. Grant.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share